Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.
about
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraLow absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysisA new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absentPreoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis.Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphomaPrognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma.Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy.Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian CancerPrognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensThe Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports.Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinomaPrognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma.Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma.Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma.Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis.Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke.CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission.Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer.High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis.Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B.
P2860
Q33558130-9451DFC5-5BB6-41D4-A94E-09E9C3710862Q33701858-A5395E4A-88C8-4319-9AAA-9E2331CF969EQ33765560-B21215A0-355F-43D0-ADDC-41A4763E3A22Q33945770-2678919E-8640-4E6B-B9DC-97A0A69E9AAFQ34226276-91A3CEED-18E7-4796-841F-CB72C257EB4BQ34257135-38E821DB-01A5-4BCF-804C-3740153C9D0EQ34281919-B8587632-8CF6-47DE-9080-6A8D6DC493B5Q34457064-70A50313-A498-47D0-BA36-B0069659AD34Q34798062-6D34A6AB-10F7-459F-AA70-8B50082C2F86Q34882773-5530D3CB-C94B-4B9B-9853-3581A150413BQ36121167-69BFEC3A-64F0-44EA-AAFB-3158923C0640Q36138851-FAED8627-2496-4A36-B1E9-A784F15DC7B9Q36145296-FA9FBAE9-409F-4472-98D4-A0DB9F5E295BQ36194582-39E70ACD-4C7B-4045-B3EC-C6CFC69D5AE4Q36317453-255F0F81-F86C-4BAD-925D-6EA779278EF2Q36439230-DDE03DB3-F4A7-439E-A139-95008E5BC2B2Q36540944-904C3D5B-2E73-4542-AEB1-DD4FA62390FDQ36563905-8CF272A4-2E65-4DB6-A72C-A5C4535EFBC0Q36673451-7B084D11-778B-460B-8A07-01F7166A4CC1Q36764919-1F5BD632-561D-452C-A511-53AC53B2CF5CQ36940100-481A69B5-CA0F-4F72-82A3-2EBFC31812DFQ37064572-FEA998EF-A0F8-45CF-AA18-B2354856B3B3Q37226075-23ACD50B-58D2-4497-A555-A57C06096BD3Q37362567-1158EA86-6C98-4225-9E10-7D3DFBB48A94Q37416557-1C8FB06A-B5F3-4CAD-9512-48022C11FB0AQ37507488-5C228090-93D9-4163-AFB9-9F38232CA80EQ37685586-6B859461-D199-429F-B2EA-2092CD269B62Q37746065-5F4C1055-F62C-4AA6-A423-6EA3AC66F9D1Q38376847-E0C54BFB-F0E7-43B4-AA4F-B3D7B74E21C1Q38677232-79A74513-39C2-44D3-804E-97C540FABB85Q38897604-2F31348C-F541-4C9F-B6A0-25FC68BD45DBQ39150349-57A4283A-DF83-42AE-A254-52045DEF885EQ39258820-B7AB1242-9F24-49C8-BFE1-02891E2D3242Q39720114-210590D1-0047-4A06-AFB8-10C1AFA6D800Q40470497-E837B901-EFDF-460F-860B-648F9C2BFCBBQ41120596-6FEA11EA-A5E5-4931-B9C2-819B365325B6Q41148150-E803B079-03E7-4353-86E5-A8F2DA5DD143Q41162196-D4675378-1CD7-4103-B655-81A4B9F58BBDQ41428549-24279E4E-89C4-480E-9369-82F64E917AE6Q42178052-5F39511E-7E5A-4744-8899-F6489E17C67A
P2860
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@ast
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@en
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@nl
type
label
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@ast
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@en
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@nl
prefLabel
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@ast
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@en
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@nl
P2093
P2860
P1433
P1476
Blood lymphocyte-to-monocyte r ...... lymphoma treated with R-CHOP.
@en
P2093
Hui-Qiang Huang
Jia-Jia Huang
Tong-Yu Lin
Wen-Qi Jiang
Wen-Xiao Wei
Ying Huang
P2860
P304
P356
10.1371/JOURNAL.PONE.0041658
P407
P577
2012-07-23T00:00:00Z